Ardelyx: Strong Execution, Fairly Valued [Seeking Alpha]
Ardelyx, Inc. (ARDX)
Last ardelyx, inc. earnings: 3/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ardelyx.com/investor-relations
Company Research
Source: Seeking Alpha
The company has done a good job managing the launch of its flagship drug tenapanor, which is now approved for two indications. Ardelyx is posting impressive sales growth and is projected to be profitable in FY2025. An updated analysis around Ardelyx follows in the paragraphs below. Today, we put Ardelyx, Inc. ( NASDAQ: ARDX in the spotlight for the first time since back in late 2022, when the stock was recommended for a small, covered call holding. The shares have moved up substantially since then. The
Show less
Read more
Impact Snapshot
Event Time:
ARDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARDX alerts
High impacting Ardelyx, Inc. news events
Weekly update
A roundup of the hottest topics
ARDX
News
- Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Ardelyx to Participate at the 2024 Jefferies Global Healthcare ConferenceGlobeNewswire
- Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults [Yahoo! Finance]Yahoo! Finance
- Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in AdultsGlobeNewswire
- Ardelyx, Inc. (NASDAQ: ARDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
ARDX
Earnings
- 5/2/24 - Beat
ARDX
Sec Filings
- 5/15/24 - Form 4
- 5/14/24 - Form 144
- 5/9/24 - Form 4
- ARDX's page on the SEC website